论文部分内容阅读
肝癌中22.7%～30.0%常发生低血糖反应的糖代谢紊乱,对发生高血糖及糖耐量降低反应的糖代谢紊乱临床报道较少.本文对16例经肝组织活检证实的肝癌进行糖耐量(OGTT)、胰岛素释放(O-GRT)、C肽释放、胰高血糖素及胰岛素抗体(IRI-Ab)等观察,旨在探讨其糖代谢紊乱的特点,现报告于下.
22.7% to 30.0% of liver cancers often suffer from hypoglycemia glycometabolic disturbances, and there are few clinical reports of hyperglycemia and impaired glucose tolerance in response to glycometabolism. In this paper, 16 cases of hepatocellular carcinoma confirmed by liver biopsy undergo glucose tolerance ( OGTT), insulin release (O-GRT), C peptide release, glucagon, and insulin antibody (IRI-Ab) were used to investigate the characteristics of glucose metabolism disorder and are reported below.